Carregant...
Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals
BACKGROUND: Newly diagnosed HIV-positive individuals are 35 to 100-fold more susceptible to Streptococcus pneumoniae infection compared to non-infected individuals. Therefore, the 23-valent pneumococcal polysaccharide vaccine (PPV23) has previously been recommended, though efficacy and effectiveness...
Guardat en:
| Publicat a: | J AIDS Clin Res |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4405239/ https://ncbi.nlm.nih.gov/pubmed/25908995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-6113.1000419 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|